241 related articles for article (PubMed ID: 28002346)
1. The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.
Yu YQ; Li J; Liao Y; Chen Q; Liao WJ; Huang J
Medicine (Baltimore); 2016 Dec; 95(51):e5734. PubMed ID: 28002346
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
3. Preoperative alkaline phosphatase-to-platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion.
Zhang Y; Zhang B; Gong L; Xiong L; Xiao X; Bu C; Liang Z; Li L; Tang B; Lu Y
Cancer Med; 2023 Sep; 12(17):17545-17558. PubMed ID: 37492981
[TBL] [Abstract][Full Text] [Related]
4. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
6. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
Jin J; Zhu P; Liao Y; Li J; Liao W; He S
Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
[TBL] [Abstract][Full Text] [Related]
8. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
Wang ZX; Peng W; Zhang XY; Wen TF; Li C
Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
11. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.
Zhao WC; Zhang HB; Yang N; Fu Y; Qian W; Chen BD; Fan LF; Yang GS
World J Gastroenterol; 2012 Jul; 18(25):3272-81. PubMed ID: 22783052
[TBL] [Abstract][Full Text] [Related]
12. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Liao W; Wang Y; Liao Y; He S; Jin J
Medicine (Baltimore); 2016 Apr; 95(14):e3345. PubMed ID: 27057915
[TBL] [Abstract][Full Text] [Related]
15. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
Liu KJ; Lv YX; Niu YM; Bu Y
Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
[TBL] [Abstract][Full Text] [Related]
17. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
19. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
20. The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma.
Shimizu T; Ishizuka M; Suzuki T; Tanaka G; Park KH; Matsumoto T; Shiraki T; Sakuraoka Y; Kato M; Aoki T; Kubota K
J Surg Oncol; 2017 Dec; 116(8):1166-1175. PubMed ID: 28853157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
